Envestnet Asset Management
CRMD icon

Envestnet Asset Management’s CorMedix CRMD Stock Holding History

Envestnet Asset Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-400
Closed -$4K – 2924
2016
Q2 		$4K Buy
+400
New +$6.09K ﹤0.01% 3056

Other funds holding CRMD

Elliott Management
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Bridgeway Capital Management
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GLRA
Gerald L. Ray & Associates Dallas, Texas $802M AUM 21.01% 1-Year Est. Return
Private Advisor Group
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Envestnet Asset Management's CRMD Position: Q3 2016 in Review

Envestnet Asset Management sold out of CorMedix (CRMD) in Q3 2016, closing a stake of 400 shares — an estimated $4K sold.

Envestnet Asset Management first reported a position in CRMD in Q2 2016 and held it in 1 quarter. The position peaked at $4K in Q2 2016. 39 funds tracked by Wall St. Rank hold CRMD as of Q3 2016.

  • Envestnet Asset Management reported no remaining CorMedix position as of Q3 2016 after selling out during the quarter.
  • Envestnet Asset Management sold 400 CorMedix shares in Q3 2016, an estimated $4K.
  • Envestnet Asset Management first reported a position in CorMedix in Q2 2016 and held it in 1 quarter.
  • Envestnet Asset Management's CorMedix position peaked at $4K in Q2 2016.
  • 39 funds tracked by Wall St. Rank held CorMedix as of Q3 2016.

Based on Envestnet Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.